Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

• A.J.J. Lammers,
• R.M. Brohet,
• R.E.P. Theunissen,
• C. Koster,
• R. Rood,
• D.W.M. Verhagen,
• K. Brinkman,
• R.J. Hassing,
• A. Dofferhoff,
• R. el Moussaoui,
• G. Hermanides,
• J. Ellerbroek,
• N. Bokhizzou,
• H. Visser,
• M. van den Berge,
• H. Bax,
• D.F. Postma,
• P.H.P. Groeneveld

Affiliations

A.J.J. Lammers

Corresponding author at: Isala Hospital, Department of Internal Medicine and Infectious Diseases, Dr van Heesweg 2, 8025 AB Zwolle, The Netherlands.; Isala, Zwolle, The Netherlands

R.M. Brohet

Department of Epidemiology and Statistics, Isala Academy, Zwolle, The Netherlands

R.E.P. Theunissen

Isala, Zwolle, The Netherlands

C. Koster

Isala, Zwolle, The Netherlands

R. Rood

Diakonessen Hospital, Utrecht, The Netherlands

D.W.M. Verhagen

Medisch Centrum Jan van Goyen, Amsterdam, The Netherlands

K. Brinkman

OLVG, Amsterdam, The Netherlands

R.J. Hassing

Rijnstate, Arnhem, The Netherlands

A. Dofferhoff

Canisius Wilhelmina Hospital, Nijmegen, The Netherlands

R. el Moussaoui

Maasstad Hospital Rotterdam, The Netherlands

G. Hermanides

Rode Kruis Hospital, Beverwijk, The Netherlands

J. Ellerbroek

Reinier de Graaf Gasthuis, Delft, The Netherlands

N. Bokhizzou

BovenIJ Hospital, Amsterdam, The Netherlands

H. Visser

Beatrix Hospital Gorinchem, The Netherlands

M. van den Berge

Admiraal de Ruiter Hospital, Goes, The Netherlands

H. Bax

Erasmus MC Rotterdam, The Netherlands

D.F. Postma

University Medical Center Groningen, Groningen, The Netherlands

P.H.P. Groeneveld

Isala, Zwolle, The Netherlands